CFG
GILD icon

Carr Financial Group’s Gilead Sciences GILD Stock Holding History

Carr Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Buy
4,227
+31
+0.7% +$4.08K 0.12% 105
2026
Q1 		$585K Buy
4,196
+39
+0.9% +$5.46K 0.15% 92
2025
Q4 		$510K Buy
4,157
+23
+0.6% +$2.79K 0.14% 102
2025
Q3 		$459K Sell
4,134
-72
-2% -$8.18K 0.13% 107
2025
Q2 		$466K Buy
4,206
+28
+0.7% +$2.98K 0.14% 100
2025
Q1 		$468K Sell
4,178
-1,472
-26% -$152K 0.15% 94
2024
Q4 		$522K Sell
5,650
-1,939
-26% -$175K 0.16% 93
2024
Q3 		$636K Buy
7,589
+65
+0.9% +$4.96K 0.19% 91
2024
Q2 		$516K Buy
7,524
+80
+1% +$5.34K 0.16% 103
2024
Q1 		$545K Sell
7,444
-195
-3% -$15K 0.18% 98
2023
Q4 		$619K Buy
7,639
+1
+0% +$78 0.23% 73
2023
Q3 		$623K Hold
7,638
– – 0.25% 70
2023
Q2 		$589K Buy
7,638
+73
+1% +$5.82K 0.24% 76
2023
Q1 		$628K Sell
7,565
-940
-11% -$77.9K 0.28% 74
2022
Q4 		$730K Buy
+8,505
New +$674K 0.38% 61

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Carr Financial Group's GILD Position: Q2 2026 in Review

Carr Financial Group increased its Gilead Sciences (GILD) stake by 0.74% in Q2 2026, buying an estimated $4.08K and bringing the position to 4,227 shares worth $534K. The position accounts for 0.12% of the portfolio, ranked #105.

Carr Financial Group first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $730K in Q4 2022. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Carr Financial Group held 4,227 shares of Gilead Sciences worth $534K as of Q2 2026.
  • Carr Financial Group bought 31 Gilead Sciences shares in Q2 2026, an estimated $4.08K.
  • Gilead Sciences made up 0.12% of Carr Financial Group's portfolio in Q2 2026, its #105 holding.
  • Carr Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Carr Financial Group's Gilead Sciences position peaked at $730K in Q4 2022.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Carr Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.